Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 9,170 shares of the firm’s stock in a transaction dated Tuesday, April 7th. The shares were sold at an average price of $23.10,
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 288,101 shares of the firm’s stock in a transaction dated Thursday, April 9th. The stock was sold at an average price of $23.79,
Franklin Resources Inc. grew its stake in shares of Alector Inc (NASDAQ:ALEC) by 41.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange

Maybe We Can Climb The Great Wall Of Worry

07:47pm, Tuesday, 07'th Apr 2020
The short- and long-term outlook is good, but mid-term risks are high. Here's what you can do now. Healthcare, consumer goods, and financials are the best secto
While most investors may focus exclusively on the millennials, it’s the baby boomers that could be the most relevant for Wall Street.
Goldman Sachs Group Inc. boosted its stake in shares of Alector Inc (NASDAQ:ALEC) by 13.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 465,937 shares o
Alector Inc (NASDAQ:ALEC) has earned a consensus recommendation of “Buy” from the eight ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a hold
Fate Therapeutics (FATE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Credit Suisse AG raised its position in Alector Inc (NASDAQ:ALEC) by 22.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned
Alector Inc (NASDAQ:ALEC) major shareholder Orbimed Advisors Llc sold 250,000 shares of the company’s stock in a transaction on Tuesday, March 31st. The stock was sold at an average price of $24.50,
Is (ALEC) Outperforming Other Medical Stocks This Year?
Is (ALEC) Outperforming Other Medical Stocks This Year?
Shareholders in Alector, Inc. (NASDAQ:ALEC) may be thrilled to learn that the analysts have just delivered a major...
Laekna Therapeutics Shanghai acquired global rights to Novartis' anti-PD-L1 antibody. Tyligand Bioscience acquired exclusive China rights to onapristone ER from
Alector, Inc. (NASDAQ:ALEC) shareholders will have a reason to smile today, with the analysts making substantial...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE